1[1]Park YK,Kim NS,Hann SK,et al.Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients[J].J Dermatol Sci,1996,11:111-120.
2[2]Cui J,Shen LY,Wang GC.Role of hair follicles in the repigmentation of vitiligo[J].J Invest Dermatol,1991,97(3):410-416.
3[3]Horikawa T,Norris DA,Yohn JJ,et al.Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis[J].J Invest Dermatol,1995,104:256-259.
4[4]Lei TC,Vieira WD,Hearing VJ.In vitro migration of melanoblasts requires matrix metalloproteinase-2:implications to vitiligo therapy by photochemotherapy[J]. Pigment Cell Research,2002,15:426-432.
5Yoshida H, Kunisada T, Grimm T, et al. Review: melanocyte migration and survival controlled by SCF/c-kit expression. J Invest Dermatol Symp Proc, 2001, 6:1-5.
6Norris A, Todd C, Graham A, et al. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo. Br J Dermatol, 1996, 134:299-306.
7Lin Z, Hoult JR, Bennett DC, et al. Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid,piperine. Planta Med, 1999, 65:600-603.
8Halaban R. Culture of melanocytes from normal, benign, and malignant lesions. Fragner RP eds. New York:Wiley, 2004. 288-318.
9Halaban R, Cheng E, Hebert DN. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants. J Invest Dermatol, 2002, 119:481-488.
10McNeely W,Goa KL.5-Methoxypsoralen.A review of its effects in psoriasis and vitiligo Drugs.1998.56(4):667-690.
